메뉴 건너뛰기




Volumn 83, Issue 2, 1997, Pages 558-559

Experience with 89-strontium treatment of painful osseous metastases from breast cancer

Author keywords

89 strontium; Bone metastases; Breast cancer

Indexed keywords

RADIOPHARMACEUTICAL AGENT; STRONTIUM 89;

EID: 0030741187     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169708300216     Document Type: Conference Paper
Times cited : (2)

References (9)
  • 1
    • 0028851570 scopus 로고
    • Bone pain palliation with strontium-89 in breast cancer patients with bone metastases and refractory bone pain
    • Berna L., Carrio I., Alonso C., Ferrè J., Estorch M., Torres G.: Bone pain palliation with strontium-89 in breast cancer patients with bone metastases and refractory bone pain. Eur. J. Nucl. Med., 22: 1101-1104, 1995
    • (1995) Eur. J. Nucl. Med. , vol.22 , pp. 1101-1104
    • Berna, L.1    Carrio, I.2    Alonso, C.3    Ferrè, J.4    Estorch, M.5    Torres, G.6
  • 2
    • 0022881267 scopus 로고
    • Sr89 therapy: Strontium kinetics in disseminated carcinoma of the prostate
    • Blake G.M., Zivanovic M.A., McEwan A.J., Ackery D.M.: Sr89 therapy: strontium kinetics in disseminated carcinoma of the prostate. Eur. J. Nucl. Med., 12: 447-454, 1986.
    • (1986) Eur. J. Nucl. Med. , vol.12 , pp. 447-454
    • Blake, G.M.1    Zivanovic, M.A.2    McEwan, A.J.3    Ackery, D.M.4
  • 3
    • 0027337223 scopus 로고
    • 85Sr contaminant as a reliable tracer of 89Sr for monitoring urinary radioactivity in patients treated with 89Sr for bone metastases
    • De Agostini A., Mascaro L., Pizzocaro C., Panarotto M.B., Bestagno M.: 85Sr contaminant as a reliable tracer of 89Sr for monitoring urinary radioactivity in patients treated with 89Sr for bone metastases. J. Nucl. Biol. Med., 37: 38-44, 1993.
    • (1993) J. Nucl. Biol. Med. , vol.37 , pp. 38-44
    • De Agostini, A.1    Mascaro, L.2    Pizzocaro, C.3    Panarotto, M.B.4    Bestagno, M.5
  • 6
    • 0025781809 scopus 로고
    • A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone
    • Lewington V.J., McEwan A.J., Ackery D.M., Bayly R.J., Keeling D.H., Macleod P.M., Porter A.T., Zivanovic M.A.: A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone. Eur. J. Cancer, 27: 954-958, 1991.
    • (1991) Eur. J. Cancer , vol.27 , pp. 954-958
    • Lewington, V.J.1    McEwan, A.J.2    Ackery, D.M.3    Bayly, R.J.4    Keeling, D.H.5    Macleod, P.M.6    Porter, A.T.7    Zivanovic, M.A.8
  • 7
    • 0027314987 scopus 로고
    • Strontium-89 as an adjuvant to external beam radiation improves pain relief and delays disease progression in advanced prostate cancer: Results of a randomized controlled trial
    • Porter A.T., McEwan A.J.: Strontium-89 as an adjuvant to external beam radiation improves pain relief and delays disease progression in advanced prostate cancer: results of a randomized controlled trial. Sem.Oncol., 20 (Suppl. 2): 38-43, 1993.
    • (1993) Sem.Oncol. , vol.20 , Issue.2 SUPPL. , pp. 38-43
    • Porter, A.T.1    McEwan, A.J.2
  • 9
    • 0029154728 scopus 로고
    • Strontium 89 therapy for the palliation of pain due to osseous metastases
    • Robinson R.G., Preston D.F., Schiefelbein M., Kirkman G.B.: Strontium 89 therapy for the palliation of pain due to osseous metastases. JAMA, 274: 420-424, 1995.
    • (1995) JAMA , vol.274 , pp. 420-424
    • Robinson, R.G.1    Preston, D.F.2    Schiefelbein, M.3    Kirkman, G.B.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.